We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Investment Ideas feature highlights: UnitedHealth Group
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 20, 2025– Today, Zacks Investment Ideas feature highlights UnitedHealth Group (UNH - Free Report) .
Follow UNH Insiders as They Buy $30 Million in Stock?
What Does UNH Do?
Zacks Rank #5 (Strong Sell) stock UnitedHealth Group is the largest health insurance company in the United States. UNH, which generated ~$400 billion in revenue last year, provides a variety of health care products and services, including health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. Meanwhile, the company boasts the largest and most diverse membership base within the managed-care organization market, giving it significant competitive advantages. Through several strategic acquisitions, UNH has transformed from a pure health insurer to a comprehensive healthcare provider.
UNH Faces Several Headwinds
Until recently, UNH stock was a model of resilience. Over the past year, however, UNH has had to weather a monumental storm of headwinds including a spike in medical costs and expenses, a cyber-attack, and the murder of UNH health insurance unit CEO Brian Thompson (and some of the backlash that came with it).
Despite the barrage of negative news headlines, UNH shares traded just shy of all-time highs as early as last month. However, UNH shares have been destroyed since then, plunging more than 50% in a month and marking the healthcare juggernaut's worst drawdown since the Great Financial Crisis of 2008.
Why Are UNH Shares Falling?
While the price action was firm until recently, investor confidence was rattled and shares unraveled rapidly after the unexpected departure of CEO Andrew Witty, a Medicare investigation into UNH, and suspended earnings guidance.
Should You Buy UNH Stock?
With negative news reaching a fever pitch, shares plunging, and investor fear rising, is now the time to buy shares of UNH?
Insiders Buy More than $30 Million of UNH
Heavy insider buying in a short period is one of the best "tells" savvy investors can observe for a prospective stock. Last week, UNH insiders put their money where their mouth is and bought a sizable amount of stock.
The latest insider trading disclosure shows that returning CEO Stephen Hemsley, who had a previous and successful stint as UNH CEO from 2006 to 2017, bought $25 million worth of shares on Friday, May 16th. Meanwhile, UNH President and CEO John F Rex accumulated nearly $5 million worth of UNH while three directors also looked to take advantage of lower stock prices. Such concentrated insider buying leads me to believe that insiders are confident that the company's issues will be resolved – and possibly soon.
Investors are Bearish on UNH Stock
"Google Trends" analyzes the popularity of search queries on the internet. The term "Short UNH" has spiked to its highest levels in history. Previous spikes have marked significant intermediate bottoms in the stock.
UNH Technicals Show Bottoming Action
The UNH daily chart illustrates significant signs of downside exhaustion, including a hammer reversal candle, extreme volume (the highest since the Great Financial Crisis), and a near-maximum oversold reading.
Bottom Line
Though UnitedHealth Group faces a barrage of negative news, recent heavy insider buying and technical indicators suggest peak pessimism and a potential bottom in the stock.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Investment Ideas feature highlights: UnitedHealth Group
For Immediate Release
Chicago, IL – May 20, 2025– Today, Zacks Investment Ideas feature highlights UnitedHealth Group (UNH - Free Report) .
Follow UNH Insiders as They Buy $30 Million in Stock?
What Does UNH Do?
Zacks Rank #5 (Strong Sell) stock UnitedHealth Group is the largest health insurance company in the United States. UNH, which generated ~$400 billion in revenue last year, provides a variety of health care products and services, including health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. Meanwhile, the company boasts the largest and most diverse membership base within the managed-care organization market, giving it significant competitive advantages. Through several strategic acquisitions, UNH has transformed from a pure health insurer to a comprehensive healthcare provider.
UNH Faces Several Headwinds
Until recently, UNH stock was a model of resilience. Over the past year, however, UNH has had to weather a monumental storm of headwinds including a spike in medical costs and expenses, a cyber-attack, and the murder of UNH health insurance unit CEO Brian Thompson (and some of the backlash that came with it).
Despite the barrage of negative news headlines, UNH shares traded just shy of all-time highs as early as last month. However, UNH shares have been destroyed since then, plunging more than 50% in a month and marking the healthcare juggernaut's worst drawdown since the Great Financial Crisis of 2008.
Why Are UNH Shares Falling?
While the price action was firm until recently, investor confidence was rattled and shares unraveled rapidly after the unexpected departure of CEO Andrew Witty, a Medicare investigation into UNH, and suspended earnings guidance.
Should You Buy UNH Stock?
With negative news reaching a fever pitch, shares plunging, and investor fear rising, is now the time to buy shares of UNH?
Insiders Buy More than $30 Million of UNH
Heavy insider buying in a short period is one of the best "tells" savvy investors can observe for a prospective stock. Last week, UNH insiders put their money where their mouth is and bought a sizable amount of stock.
The latest insider trading disclosure shows that returning CEO Stephen Hemsley, who had a previous and successful stint as UNH CEO from 2006 to 2017, bought $25 million worth of shares on Friday, May 16th. Meanwhile, UNH President and CEO John F Rex accumulated nearly $5 million worth of UNH while three directors also looked to take advantage of lower stock prices. Such concentrated insider buying leads me to believe that insiders are confident that the company's issues will be resolved – and possibly soon.
Investors are Bearish on UNH Stock
"Google Trends" analyzes the popularity of search queries on the internet. The term "Short UNH" has spiked to its highest levels in history. Previous spikes have marked significant intermediate bottoms in the stock.
UNH Technicals Show Bottoming Action
The UNH daily chart illustrates significant signs of downside exhaustion, including a hammer reversal candle, extreme volume (the highest since the Great Financial Crisis), and a near-maximum oversold reading.
Bottom Line
Though UnitedHealth Group faces a barrage of negative news, recent heavy insider buying and technical indicators suggest peak pessimism and a potential bottom in the stock.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.